Prostatis Group’s Vanguard Mid-Cap Value ETF VOE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61,525
Closed -$62.6K 244
2023
Q2
$62.6K Buy
+61,525
New +$8.2M 0.03% 161
2022
Q1
Sell
-2,143
Closed -$322K 106
2021
Q4
$322K Sell
2,143
-814
-28% -$120K 0.2% 70
2021
Q3
$413K Sell
2,957
-86
-3% -$12.2K 0.25% 63
2021
Q2
$427K Buy
3,043
+79
+3% +$11.2K 0.29% 63
2021
Q1
$400K Buy
2,964
+392
+15% +$50.2K 0.31% 69
2020
Q4
$306K Buy
+2,572
New +$288K 0.26% 66

Other funds holding VOE

Prostatis Group's VOE Position: Q3 2023 in Review

Prostatis Group sold out of Vanguard Mid-Cap Value ETF (VOE) in Q3 2023, closing a stake of 61,525 shares — an estimated $62.6K sold.

Prostatis Group first reported a position in VOE in Q4 2020 and held it in 6 quarters. The position peaked at $427K in Q2 2021. 890 funds tracked by Wall St. Rank hold VOE as of Q3 2023.

  • Prostatis Group reported no remaining Vanguard Mid-Cap Value ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 61,525 Vanguard Mid-Cap Value ETF shares in Q3 2023, an estimated $62.6K.
  • Prostatis Group first reported a position in Vanguard Mid-Cap Value ETF in Q4 2020 and held it in 6 quarters.
  • Prostatis Group's Vanguard Mid-Cap Value ETF position peaked at $427K in Q2 2021.
  • 890 funds tracked by Wall St. Rank held Vanguard Mid-Cap Value ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.